A study that elucidated the genomic landscape of ESCC in 133 patients found the most frequent somatic mutations included TP53 (93%), CCND1 (33%), CDKN2A (20%), NFE2L2 (10%), and RB1 (9%) [17]. This evidence concerns the gene CDKN2A and esophageal squamous cell carcinoma.